Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)


      News provided by

      Camber Pharmaceuticals

      Feb 28, 2019, 12:39 ET

      Share this article

      Share this article


      PISCATAWAY, N.J., Feb. 28, 2019 /PRNewswire/ --

      Company Contact: Stericycle
      Name: Stericycle Customer Service – Recalls – Event 4862
      Phone Number: 1-888-275-0506
      Email: [email protected]

      Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer).

      NMBA is a potential human carcinogen. To date, Camber has not received any reports of adverse events related to this recall.  

      Losartan Potassium, USP, is a prescription medication used to treat high blood pressure and congestive heart failure and is packaged in 30ct, 90ct, 500ct, 1000ct bottles. The identifying NDC #s associated with Camber's product as are follows: Losartan 25 mg 31722-700-90, 31722-700-05, 31722-700-10; Losartan 50 mg 31722-701-30, 31722-701-90, 31722-701-10; and Losartan 100 mg 31722-702-30, 31722-702-90, and 31722-702-10.

      The affected Losartan includes 87 lot numbers which are listed below:

      NDC

      Name and Strength

      Count

      Lot#

      Expiry

      31722-700-90

      Losartan Potassium Tablets USP 25 mg

      90

      LOP17026B

      Sep-19

      31722-700-90

      Losartan Potassium Tablets USP 25 mg

      90

      LOP17050

      Sep-19

      31722-700-90

      Losartan Potassium Tablets USP 25 mg

      90

      LOP17051

      Sep-19

      31722-700-90

      Losartan Potassium Tablets USP 25 mg

      90

      LOP17052

      Sep-19

      31722-700-90

      Losartan Potassium Tablets USP 25 mg

      90

      LOP17053

      Sep-19

      31722-700-90

      Losartan Potassium Tablets USP 25 mg

      90

      LOP17061

      Oct-19

      31722-700-90

      Losartan Potassium Tablets USP 25 mg

      90

      LOP18035

      Dec-19

      31722-700-90

      Losartan Potassium Tablets USP 25 mg

      90

      LOP18036

      Dec-19

      31722-700-05

      Losartan Potassium Tablets USP 25 mg

      500

      LOP17026

      Sep-19

      31722-700-10

      Losartan Potassium Tablets USP 25 mg

      1000

      LOP17006

      May-19

      31722-700-10

      Losartan Potassium Tablets USP 25 mg

      1000

      LOP17025

      Sep-19

      31722-700-10

      Losartan Potassium Tablets USP 25 mg

      1000

      LOP17068

      Oct-19

      31722-700-10

      Losartan Potassium Tablets USP 25 mg

      1000

      LOP18037

      Dec-19

      31722-700-10

      Losartan Potassium Tablets USP 25 mg

      1000

      LOP18038

      Dec-19

      31722-700-10

      Losartan Potassium Tablets USP 25 mg

      1000

      LOP18039

      Dec-19

      31722-700-10

      Losartan Potassium Tablets USP 25 mg

      1000

      LOP18057

      Jan-20

      31722-701-30

      Losartan Potassium Tablets USP 50 mg

      30

      LOP17028C

      Sep-19

      31722-701-30

      Losartan Potassium Tablets USP 50 mg

      30

      LOP17064A

      Nov-19

      31722-701-90

      Losartan Potassium Tablets USP 50 mg

      90

      LOP17027

      Sep-19

      31722-701-90

      Losartan Potassium Tablets USP 50 mg

      90

      LOP17063

      Nov-19

      31722-701-90

      Losartan Potassium Tablets USP 50 mg

      90

      LOP17093

      Nov-19

      31722-701-90

      Losartan Potassium Tablets USP 50 mg

      90

      LOP17094

      Dec-19

      31722-701-90

      Losartan Potassium Tablets USP 50 mg

      90

      LOP17095

      Dec-19

      31722-701-90

      Losartan Potassium Tablets USP 50 mg

      90

      LOP17097A

      Dec-19

      31722-701-90

      Losartan Potassium Tablets USP 50 mg

      90

      LOP17105

      Dec-19

      31722-701-90

      Losartan Potassium Tablets USP 50 mg

      90

      LOP17107

      Dec-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP17004

      Dec-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP17028B

      Sep-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP17048

      Oct-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP17049

      Oct-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP17056

      Nov-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP17073

      Nov-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP17074

      Nov-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP17076

      Nov-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP17096

      Dec-19

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP18077A

      Feb-20

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP18078

      Feb-20

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP18079

      Feb-20

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP18080

      Feb-20

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP18081

      Mar-20

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP18084

      Mar-20

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP18095

      Mar-20

      31722-701-10

      Losartan Potassium Tablets USP 50 mg

      1000

      LOP18096

      Mar-20

      31722-702-30

      Losartan Potassium Tablets USP 100 mg

      30

      LOP17011

      Aug-19

      31722-702-30

      Losartan Potassium Tablets USP 100 mg

      30

      LOP17087

      Nov-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP17012

      Aug-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP17013

      Aug-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP17042

      Oct-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP17043

      Oct-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP17044

      Nov-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP17045

      Nov-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP18024

      Dec-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP18025

      Dec-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP18026

      Dec-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP18027

      Dec-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP18028

      Dec-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP18029

      Dec-19

      31722-702-90

      Losartan Potassium Tablets USP 100 mg

      90

      LOP18030

      Dec-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP17005

      May-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP17014

      Aug-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP17016

      Sep-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP17023

      Sep-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP17083

      Oct-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP17084

      Nov-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP17085

      Nov-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP17086

      Nov-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18021

      Dec-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18022

      Dec-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18023

      Dec-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18031

      Dec-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18032

      Dec-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18033

      Dec-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18050

      Dec-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18051

      Dec-19

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18109

      Mar-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18111

      Mar-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18122

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18123

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18124

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18125

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18126

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18127

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18128

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18129

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18130

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18131C

      Jun-20

      31722-702-10

      Losartan Potassium Tablets USP 100 mg

      1000

      LOP18133

      Jun-20

      Losartan Potassium Tablets were distributed Nationwide to Wholesalers, Distributors, Retail Pharmacies, and Mail Order Pharmacies.

      Stericycle is notifying Camber's distributors and other customers by recall letter and arranging for return of recalled product of Losartan Potassium Tablets.

      Consumers should contact their doctor for further guidance and potential change of treatment before they stop taking the product. Pharmacies and healthcare facilities that have the product being recalled should stop using and dispensing the product immediately.

      Consumers with questions regarding this recall can contact Camber Pharmaceuticals' Med Line at 1-866-495-1995 Monday – Friday, 9am – 5pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

      Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

      • Complete and submit the report Online: www.fda.gov/medwatch/report.htm
      • Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

      This recall is being conducted with the knowledge of the U.S. Food and Drug administration.

      SOURCE Camber Pharmaceuticals

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.